Aelis Farma's Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome
Aelis Farma (Paris:AELIS), a clinical stage biopharmaceutical company specializing in the development of treatments for brain diseases, announced positive results from its phase 1 clinical trials in healthy volunteers with its drug candidate AEF0217.
